Technescan MAG3 (MALLINCKRODT NUCLEAR MEDICINE LLC)


Welcome to the PulseAid listing for the Technescan MAG3 drug offered from MALLINCKRODT NUCLEAR MEDICINE LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: MALLINCKRODT NUCLEAR MEDICINE LLC
NON-PROPRIETARY NAME: Technescan Tc 99m Mertiatide
SUBSTANCE NAME: BETIATIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1990-06-15
END MARKETING DATE: 0000-00-00


Technescan MAG3 HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTechnescan MAG3 from MALLINCKRODT NUCLEAR MEDICINE LLC
LABELER NAME: MALLINCKRODT NUCLEAR MEDICINE LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/1)
START MARKETING DATE: 1990-06-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69945-096_38eab466-50aa-4f39-90d0-62f80a49f1d5
PRODUCT NDC: 69945-096
APPLICATION NUMBER: NDA019882

Other BETIATIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
MALLINCKRODT NUCLEAR MEDICINE LLCTechnescan MAG3